SEC Form 4 · accession 0001209191-15-085458
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence J. Hineline
Officer — VP of Finance CFO
Period of report
Nov 24, 2015
Accepted (ET)
Dec 15, 2015 · 8:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 24, 2015 | M | 5,000 | $0.60 | A | 64,700 | D | |
| Common Stock | Dec 14, 2015 | M | 7,500 | $0.60 | A | 72,200 | D | |
| Common StockF2 | Dec 14, 2015 | S | 9,893 | $49.88 | D | 62,307 | D | |
| Common StockF3 | Dec 14, 2015 | S | 4,282 | $50.93 | D | 58,025 | D | |
| Common StockF4 | Dec 14, 2015 | S | 5,725 | $52.01 | D | 52,300 | D | |
| Common StockF5 | Dec 14, 2015 | S | 2,600 | $52.63 | D | 49,700 | D | |
| Common Stock | Dec 15, 2015 | M | 12,500 | $1.36 | A | 62,200 | D | |
| Common Stock | Dec 15, 2015 | M | 12,500 | $1.50 | A | 74,700 | D | |
| Common StockF6 | Dec 15, 2015 | S | 11,236 | $51.50 | D | 63,464 | D | |
| Common StockF7 | Dec 15, 2015 | S | 11,264 | $52.43 | D | 52,200 | D | |
| Common Stock | Dec 15, 2015 | M | 10,000 | $1.50 | A | 62,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F8 | $0.60 | Nov 24, 2015 | M | 5,000 | D | — | Dec 14, 2015 | Common Stock | 5,000 | 7,500 | D |
| Stock Option (right to buy)F8 | $0.60 | Dec 14, 2015 | M | 7,500 | D | — | Dec 14, 2015 | Common Stock | 7,500 | 0 | D |
| Stock Option (right to buy)F8 | $1.36 | Dec 15, 2015 | M | 12,500 | D | — | Dec 5, 2016 | Common Stock | 12,500 | 0 | D |
| Stock Option (right to buy)F8 | $1.50 | Dec 15, 2015 | M | 12,500 | D | — | Dec 12, 2017 | Common Stock | 12,500 | 0 | D |
| Stock Option (right to buy)F8 | $1.50 | Dec 15, 2015 | M | 10,000 | D | — | Dec 18, 2018 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.43 to $50.42, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.44 to $51.40, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.47 to $52.45, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.47 to $53.44, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.95 to $51.94, inclusive.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.95 to $52.93, inclusive.
- F8All shares underlying this option have vested.
Remarks
The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) of this Form 4.